Martin Stuart, PhD
President & CEO
Martin Stuart, PhD, is a serial entrepreneur who has enjoyed more than 30 years of commercial success introducing new and complex technologies to the Life Science and Healthcare markets.
Operating largely at the intersection of science and business, Martin’s forte is transforming technology-driven companies into market-driven organizations with solid business acumen. No stranger to the start-up world, he has taken two companies from inception to $50+M and ultimately exit through acquisition or public markets. He has built and managed sales channels in more than 40 countries around the world, delivering commercial success.
Dr. Stuart spent 8+ years with Aperio Technologies, where he was responsible for building commercial operations including sales, marketing and services. He championed several key initiatives such as the Pathology Visions Conference, now the largest digital pathology industry conference in the world, and also fostered the collaboration to digitize the world famous pathology slide collection from Dr. Juan Rosai. These initiatives, coupled with solid, sustained, commercial growth, propelled Aperio to be the undisputed leader in the global digital pathology market. Aperio was acquired by Leica Biosystems, a Danaher Company, in 2012.
Dr. Stuart was awarded a PhD from The University College of North Wales for his work on Ultra-High-Resolution Imaging of Langmuir Blodgett films and a BSc in Physics from London South Bank University, England.
Chief Technology Officer
Victor is Mikroscan’s Co-Founder and Chief Technology Officer. He has been involved in the microscopy industry for over 30 years and has deep technical experience in high performance and histology-based microcopy techniques.
Victor’s career started with McBain Instruments, a provider of specialized microscopy products, as a service technician and photomicrography expert. In this role he became expert in the creation of 35mm and Polaroid “photowalls”- early predecessors to modern large-format digital pathology images. Victor went on to work in McBain’s Special Products and Engineering Departments where he developed the Papnet Cytology Quality Assurance system and digital imaging technology used to record histology-based tissue block faces with sections on individual slides. Further work with McBain Instruments resulted in custom solutions for high performance microscopy applications like 3D confocal imaging, deconvolution, calcium ratiometric imaging, GFP, fluorescence and brain mapping. Victor’s microscopy solutions are found in prestigious institutions such as the Gonda (Goldschmeid) Neuroscience and Genetics Institute and Brain Research Institute, both at University of California- Los Angeles.
Victor’s interest and involvement in histology-based digital imaging led him to co-found Mikroscan, where he has been named the primary inventor on two submitted patents, and one provisional patent for network-based pathology with a desktop imaging slide scanner.
Stelios Andronikou is an accomplished Financial professional with over 20 years successful experience in large public companies and venture funded start-up organizations.
Stelios is experienced in venture funding, private debt and equity offerings, M&A, public filings and possesses a wealth of international operations experience in healthcare and life sciences industries, supporting high growth organizations in complex regulated markets. His strategic thinking backed up with deep hands-on tactical expertise provides a solid foundation for any rapidly developing business by empowering other departments to focus on their core objectives.
Prior to Mikroscan, Stelios was the Controller of Aperio, acquired by Leica Microsystems, a Danaher Company. He possesses a BS in Business Administration from California State University Fresno and an MBA from National University.
Software Engineering Manager
James Crowe is a seasoned IT professional with over 15 years of software development experience and is the principal architect for Mikroscan’s software products. An expert in electro-optical software control systems for various digital imaging devices, James was instrumental in the development of Mikroscan’s flagship product the SL5.
Prior to joining Mikroscan, James served as a database analyst/programmer at Synteract, supporting Phase I-IV clinical trials for biotech and pharmaceutical industries. He successfully lead numerous rescue studies for major pharmaceutical companies.
James was awarded both his BS and MS degrees in Computer Science from California State University San Marcos.
Danielle Pirain joins Mikroscan as an Application Specialist with over 15 years in the pathology lab setting. Prior to coming to Mikroscan, she has worked as a pathologist assistant, MOHS histologist and researcher in established institutions such as Cleveland Clinic Foundation and the University of Pittsburgh Medical Center. Her research concentration was on patient safety and pathology process improvement. She is an ASCP certified Medical Technologist and a member of the ASMH.
Inside Sales Representative
Kanae Wilcox-Perrotta has over 5 years of experience cultivating customer relationships within the medical device industry. Prior to Mikroscan, Kanae was responsible for medical device supply chain management in the area of sleep apnea. In addition, she drove customer operational improvements utilizing evidence based analytics at Vertex Consulting. Currently, at Mikroscan, Kanae educates customers on Mikroscan technologies and services, helping customers see business opportunities with telepathology and digital pathology solutions.
Kanae is a graduate of Colorado State University, where she holds BS degrees in Food Nutrition Sciences and Business Administration.
Technical Operations Supervisor
Adam Uribe is responsible for all technical aspects of final assembly, calibration and system validation. In addition, Adam’s analytical and diagnostic skills make him a key member of the client services team.
An accomplished biotechnology professional, Adam has more than 20 years experience in research and product development in both academic and private sectors.
Adam started his career in academia within the Department of Medicine, University of California, San Diego, studying transcription factors in early mammalian embryogenesis. He managed a dedicated facility producing transgenic and chimeric mouse lines. In addition, as a cost containment initiative, Adam established an in-house cryogenics facility.
He has worked for numerous organizations in roles of increasing responsibility, including Hybritech, Nanogen, JMAR Technologies and Medipacs.
A San Diego native, Adam holds a Bachelor’s Degree in Biology from University of California San Diego.